FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W84436552> ?p ?o ?g. }

• W84436552 endingPage "2590" @default.
• W84436552 startingPage "2590" @default.
• W84436552 abstract "Abstract Venous thrombosis (VT) is considered to be a multifactorial disorder in which several genetic and acquired risk factors interact dynamically. Coagulation factor XIII (FXIII) is an enzyme that participates in the final steps of the coagulation cascade. A number of gene variations have been described in both FXIII A and B subunits. FXIIIA Val34Leu, Tyr204Phe and Pro564Leu polymorphisms have been associated to increased specific activity of FXIII, and FXIIIA Val34Leu has been claimed to be protective against VT in several studies. In the FXIII B subunit, two common polymorphisms (His95Arg and G30899A) have been also reported, but its association with VT is uncertain. In addition, possible interactive effects between these polymorphisms and between these polymorphisms and the two most prevalent mutations associated with VT, factor V Leiden (FVL) and factor II (FII) G20210A mutations, have not been explored. In the present study, we determined the prevalence of the five above-mentioned FXIII polymorphisms in 418 consecutive patients with an objective diagnosis of VT and in 418 age-, gender- and race-matched controls in the BRATROS (Brazilian Thrombosis Study) case-control investigation. Genotyping for Val34Leu, Pro564Leu, His95Arg and G30899A was performed by PCR amplification followed by MseI, BstUI, NsiI and BspHI restriction digestion analysis, respectively. Genotyping for Tyr204Phe was performed by single-strand conformation polymorphism (SSCP) analysis followed by DNA sequencing of samples showing mobility shifts. Odds ratios (OR) as a measure of relative risks of VT, and 95% confidence intervals (CI95), were calculated. Stratified analyses were performed to search for interactions between the FXIII polymorphisms and between the FXIII polymorphisms, FVL and FII G20210A. Overall OR for VT linked to Val34Leu was 0,78 (CI95: 0,59–1,03); OR for heterozygotes (HT) was 0,85 (CI95: 0,64–1,13) and for homozygotes (HM) the OR was 0,33 (CI95: 0,15–0,71). Overall OR linked to G30899A was 1,06 (CI95: 0,81–1,39); OR for HT was 0,96 (CI95: 0,72–1,28) and for HM the OR was 1,58 (IC95: 1,00–2,49). No impacts over the risk of VT were observed, related to the other three polymorphisms investigated. When stratified analyses were performed to search for interactions, a trend towards increased risk of VT was detected when the Val34 allele was co-inherited with the Arg95 allele (OR 1,45; CI95: 0,97–2,18), and a trend towards decreased thrombotic risk was verified when the Leu34 and Leu564 alleles were co-inherited (OR 0,63; CI95: 0,40–1,00). Furthermore, increased risk for VT was observed when the mutant A30899 allele was co-inherited with FII G20210A, pointing to a notable interaction effect (OR 18,29; CI95: 2,41–138,87). The data confirm that homozygosity for FXIII Val34Leu is protective against the occurrence of VT in our population. In addition, the findings point to a previously unknown increased risk of VT related to homozygosity for FXIIIB G30899A of the order of 58%. Lastly, an impressive interactive effect (18-fold increased risk of VT) between FXIIIB G30899A and FII G20210A is reported for the first time. Taken together, the findings from the present investigation strengthen the clinical significance of FXIII in vascular thrombosis and reinforce the concept of VT as a multigenic disease." @default.
• W84436552 created "2016-06-24" @default.
• W84436552 creator A5007632771 @default.
• W84436552 creator A5009039122 @default.
• W84436552 creator A5010187682 @default.
• W84436552 creator A5012116323 @default.
• W84436552 creator A5069338585 @default.
• W84436552 creator A5069948023 @default.
• W84436552 creator A5072335040 @default.
• W84436552 creator A5079809180 @default.
• W84436552 creator A5088873384 @default.
• W84436552 date "2004-11-16" @default.
• W84436552 modified "2023-10-16" @default.
• W84436552 title "New Interactive Effects Involving Factor XIII Gene Polymorphisms in Venous Thrombotic Disease." @default.
• W84436552 doi "https://doi.org/10.1182/blood.v104.11.2590.2590" @default.
• W84436552 hasPublicationYear "2004" @default.
• W84436552 type Work @default.
• W84436552 sameAs 84436552 @default.
• W84436552 citedByCount "1" @default.
• W84436552 countsByYear W844365522022 @default.
• W84436552 crossrefType "journal-article" @default.
• W84436552 hasAuthorship W84436552A5007632771 @default.
• W84436552 hasAuthorship W84436552A5009039122 @default.
• W84436552 hasAuthorship W84436552A5010187682 @default.
• W84436552 hasAuthorship W84436552A5012116323 @default.
• W84436552 hasAuthorship W84436552A5069338585 @default.
• W84436552 hasAuthorship W84436552A5069948023 @default.
• W84436552 hasAuthorship W84436552A5072335040 @default.
• W84436552 hasAuthorship W84436552A5079809180 @default.
• W84436552 hasAuthorship W84436552A5088873384 @default.
• W84436552 hasConcept C104317684 @default.
• W84436552 hasConcept C126322002 @default.
• W84436552 hasConcept C135763542 @default.
• W84436552 hasConcept C146304588 @default.
• W84436552 hasConcept C153209595 @default.
• W84436552 hasConcept C156957248 @default.
• W84436552 hasConcept C2777175894 @default.
• W84436552 hasConcept C2779036427 @default.
• W84436552 hasConcept C2779672106 @default.
• W84436552 hasConcept C2780011451 @default.
• W84436552 hasConcept C2780868729 @default.
• W84436552 hasConcept C31467283 @default.
• W84436552 hasConcept C50440223 @default.
• W84436552 hasConcept C54355233 @default.
• W84436552 hasConcept C71924100 @default.
• W84436552 hasConcept C86803240 @default.
• W84436552 hasConcept C90924648 @default.
• W84436552 hasConceptScore W84436552C104317684 @default.
• W84436552 hasConceptScore W84436552C126322002 @default.
• W84436552 hasConceptScore W84436552C135763542 @default.
• W84436552 hasConceptScore W84436552C146304588 @default.
• W84436552 hasConceptScore W84436552C153209595 @default.
• W84436552 hasConceptScore W84436552C156957248 @default.
• W84436552 hasConceptScore W84436552C2777175894 @default.
• W84436552 hasConceptScore W84436552C2779036427 @default.
• W84436552 hasConceptScore W84436552C2779672106 @default.
• W84436552 hasConceptScore W84436552C2780011451 @default.
• W84436552 hasConceptScore W84436552C2780868729 @default.
• W84436552 hasConceptScore W84436552C31467283 @default.
• W84436552 hasConceptScore W84436552C50440223 @default.
• W84436552 hasConceptScore W84436552C54355233 @default.
• W84436552 hasConceptScore W84436552C71924100 @default.
• W84436552 hasConceptScore W84436552C86803240 @default.
• W84436552 hasConceptScore W84436552C90924648 @default.
• W84436552 hasIssue "11" @default.
• W84436552 hasLocation W844365521 @default.
• W84436552 hasOpenAccess W84436552 @default.
• W84436552 hasPrimaryLocation W844365521 @default.
• W84436552 hasRelatedWork W1493666455 @default.
• W84436552 hasRelatedWork W1792182519 @default.
• W84436552 hasRelatedWork W1847230559 @default.
• W84436552 hasRelatedWork W2002875273 @default.
• W84436552 hasRelatedWork W2024916400 @default.
• W84436552 hasRelatedWork W2153103369 @default.
• W84436552 hasRelatedWork W2158144878 @default.
• W84436552 hasRelatedWork W2163747366 @default.
• W84436552 hasRelatedWork W4296980321 @default.
• W84436552 hasRelatedWork W2525545011 @default.
• W84436552 hasVolume "104" @default.
• W84436552 isParatext "false" @default.
• W84436552 isRetracted "false" @default.
• W84436552 magId "84436552" @default.
• W84436552 workType "article" @default.